BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• 

  Manufacturing

  Trump’s Reshoring Drive Raises Questions About Supply Resilience

  Some observers see risks to becoming over-reliant on local facilities, noting the potential need for trade partners if domestic production is disrupted.

  September 16, 2025

   · 

  4 min read

   · 

  Nick Paul Taylor
• 

  Opinion

  For Scalable Success in Cell Therapy, Regional Manufacturing Is the Smart Middle Path

  The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

  September 16, 2025

   · 

  5 min read

   · 

  Jane Koo
• 

  Vaccines

  Kennedy Names New ACIP Members as Panel Quiets COVID-19 Vaccine Developers Ahead of Meeting

  Like the first batch of appointees to the CDC’s vaccine advisory committee, several of the new panelists have documented histories of vaccine and COVID-19 skepticism.

  September 16, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug pricing

  Sanofi Joins Growing Group of Pharmas Pulling Back From UK

  Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region.

  September 16, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts

  Both Novo Nordisk and Eli Lilly are eyeing regulatory advancements for their obesity blockbusters as the European Association for the Study of Diabetes’ annual conference continues this week.

  September 16, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial

  The sub-analysis, presented at the European Association for the Study of Diabetes congress, showed improved safety data to counteract past tolerability issues.

  September 16, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• 

  Gene therapy

  Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns

  A new analyst survey suggests that doctors are still prescribing Sarepta’s Elevidys, even after a series of deaths in certain populations marred the gene therapy’s record.

  September 16, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Rare diseases

  Stealth, Barth Community Await FDA Verdict With ‘Everything at Stake’

  A decade-long journey is coming to an end for Stealth BioTherapeutics and the Barth syndrome community. Will it result in the first-ever treatment for this ultra-rare mitochondrial disease, or possibly the end of the road for the Massachusetts-based biotech?

  September 16, 2025

   · 

  6 min read

   · 

  Heather McKenzie
• Press Releases

  Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 15, 2025

  September 16, 2025

   · 

  1 min read
• Press Releases

  Genesee Scientific Acquires Jade Scientific, Expanding Capabilities in Lab Essentials Market

  September 16, 2025

   · 

  2 min read